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A simple and sensitive assay for DNA-protein cross-links has been used as a biomarker of
chromate exposure and early carcinogenic effects. Pilot studies of DNA-protein cross-links in
peripheral blood lymphocytes have been conducted with individuals who had higher exposure to
chromate, including welders, and with individuals who had lower levels of exposure such as
residents living in a chromium-contaminated area in Jersey City, New Jersey. Studies were also
conducted in two Bulgarian cities (Jambol and Burgas) with different levels of air pollution and
Cr(VI) exposure and in chrome platers in Bulgaria who had high exposure to chromate. DNA-
protein cross-links in U.S. welders and in individuals living in Hudson County, New Jersey around
chromium-contaminated areas were significantly higher compared to matched controls. Although
blood and urinary levels of chromium were not extensively studied in these populations, we were
able to obtain these measurements in the Bulgarian population. Chromium levels in red blood
cells of controls living in Burgas were in the order of 1 to 2 ppb chromium, and these individuals
had the lowest levels of DNA-protein cross-links. However, the chromium levels in Jambol
ranged from about 2 to 7 ppb in red blood cells of city residents to about 22 ppb in chrome
platers. DNA-protein cross-links were saturated at about 7 to 8 ppb chromium in the red blood
cells, and cross-links correlated well only with chromium levels in red blood cells. Urinary
chromium levels did not correlate well with either DNA-protein cross-links or chromium levels in
with red blood cells. Environ Health Perspect 104(Suppl 5):917-919 (1996)
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Introduction
Despite substantial evidence ofthe carcino-
genic activity of hexavalent chromium
compounds, it is still widely used in indus-
trial situations (1). Hexavalent chromium
compounds can be found in cement and is
used as an antirust agent in water cooling
systems (1). Workers become exposed to it
during welding and chrome plating (1).
There are also areas where rocks rich in
Cr(VI) have been used as landfill, such as
in Hudson County, NewJersey (2). Hexa-
valent chromium is a major contaminant
in many Superfund sites (40% ofall sites).
Epidemiological studies have demon-
strated a strong association ofoccupational
exposure to chromate particles in chrome
plating and refinery workers and the induc-
tion ofnasal and respiratory cancers (1,3).
Hexavalent chromium-containing com-
pounds have been shown to induce respira-
tory cancers in experimental animals as
well (3). Hexavalent chromium-containing
compounds are active in all genotoxic and
mutagenicity assays (1,3). The potent
genotoxic and carcinogenic activity of
hexavalent chromium is due to its rapid
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uptake into cells (4). Hexavalent chromium
exists as an oxyanion at physiological pH
and is actively taken up by an anion trans-
port system, which is present in all mam-
malian cells. In contrast, the trivalent form
of chromium is taken up 1000-fold less
readily than hexavalent chromium com-
pounds, and, in general, trivalent chromium
complexes exhibit about 1000-fold lower
toxic activity in cellular systems compared
to hexavalent chromium (3,4).
Intracellularly, many of the genotoxic
effects of hexavalent chromium are attrib-
utable to its reduction to trivalent chromium
(5-9). There are some unique chemical
features of Cr(VI)-+Cr(III) reduction sys-
tem in cells. For example, trivalent chrom-
ium forms octahedral complexes involving
six ligands ofcoordination. The binding of
Cr(III) to various ligands is considered very
stable. However, during the conversion of
hexavalent chromium to trivalent chro-
mium, oxygen radicals are generated and
chromium forms various intermediates,
such as Cr(V) and Cr(IV), which exhibit
different reactivities from Cr(III) (10-12).
This creates a unique set ofreactions that is
not characteristic of those occurring with
Cr(III) alone. The Cr(V) and Cr(IV) inter-
mediates are unstable and eventually form
Cr(III) in cells (10-12). A major intracel-
lular reducer of hexavalent chromium to
trivalent chromium is ascorbic acid, but
glutathione and other reducing agents can
also catalyze these reactions (13).
Studies conducted in our laboratory
have demonstrated that trivalent chro-
mium ultimately participates in the cross-
linking ofproteins to DNA (8). Although
DNA-protein cross-links (DPC) represent
a lesion that can be detected in cells after
exposure to hexavalent chromium com-
pounds, they are not the only DNA lesion
induced by chromate (14). For example,
DNA-DNA cross-links involve trivalent
chromium (14). Trivalent chromium can
also complex amino acids and glutathione
to DNA (15). In fact, complexes ofamino
acids and glutathione with Cr(III)
accounted for about 50% of all Cr(III)
DNA adducts and are considerably more
abundant than complexes ofproteins cross-
linked with DNA (16). However, the
detection ofprotein-DNA cross-links can
be accomplished with a simple and sensi-
tive assay, whereas other types of Cr(III)
DNA adducts cannot be as easily detected.
In this report, we summarize the data
that we have obtained on studies of DPC
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as a biomarker ofhuman exposure to chro-
mate. We present a preliminary report on
our Bulgarian studies, which will be pub-
lished in more detail elsewhere.
Materials and Methods
DNA-protein cross-links were assessed by
the method ofZhitkovich and Costa (17),
as recently modified (18). Peripheral blood
mononuclear cells were isolated by a stan-
dard Ficol sodium diatrizoate protocol
using Histopaque-1077 (Sigma). The iso-
lated mononuclear cells were washed in
phosphate buffered saline, counted and
2x 106 cells were lysed in 0.5 ml of0.5%
sodium dodecyl sulfate (SDS), 20 mM
Tris-HCI (pH 7.5). The lysed samples were
placed at-700C until analyzed for DPC.
Samples were thawed at 370C and the
DNA was sheared by passage of the cell
lysates 4 times through a 21-gauge needle.
The lysate was expelled into a tube by
applying high pressure and 0.5 ml of 100
mM KCI, 20 mM Tris (pH 7.5) was then
added. The content was mixed by vortex-
ing the tube for 5 sec at maximum speed,
and the tubes were then heated for 10 min
at 65°C. Samples were removed from the
water bath, inverted 3 times, and then
placed on ice for 5 min to form a K-SDS
precipitate. The precipitate was collected
by centrifugation at 6000g for 5 min at
40C. The supernatant was removed and the
pellet was resuspended in 100 mM ofKCI,
20 mM Tris-HCl (pH 7.5) by briefvor-
texing at the highest setting. The samples
were again heated at 650C for 10 min and
the washing steps, as well as the heating
steps described above, were repeated 2
more times. Protein linked to DNA was
released from the final potassium dodecyl
sulfate precipitate by treatment with 0.2
mg/ml proteinase K in a 0.5-ml solution
containing 100 mM KCl, 20 mM Tris-
HCl (pH 7.5), and 10 mM EDTA. The
samples were then incubated at 500C for 3
hr. At this point the samples were stored at
-700C. Fifty microliters of4 mg/ml bovine
serum albumin (BSA) was added to each
tube and the samples were placed on ice.
The tubes were centrifuged at 12,000xg
for 10 min at 4°C, and the supernatant was
taken to determine the quantity of DNA.
It is important at this point to avoid dis-
turbing the potassium dodecyl sulfate pel-
let while aspirating the supernatant because
dodecyl sulfate interfered with the Hoechst
33258 assay.
DNA was detected using Hoechst
33258. DNA standards were prepared at
concentrations of 100, 200, 500, 1000,
2000, and 5000 ng/ml. We took 0.5 ml of
a standard DNA or the entire supernatant
from the potassium dodecyl sulfate pellet
and mixed it with 0.5 ml of freshly pre-
pared Hoechst dye reagent, 250 ng/ml.
Precaution was taken to avoid exposure to
light at this point, and the samples were
placed in the dark for 10 min. Fluorescence
was measured by setting excitation wave-
length at 365 and emission wavelength at
450 to 460 nm. The DNA standard curve
and samples were read for fluorescence. A
BSA tube was used as the standard blank.
The percent of DNA precipated was taken
as a measure ofDPC (17,18).
DNA-protein cross-links have been
examined in various populations. The
exposed and control groups had similar
demographic characteristics, except that all
exposed were males and five ofthe controls
were females. All individuals recruited for
this study were white. Exposed and control
groups were similar with respect to alcohol
consumption and smoking status. No con-
sumption ofvitamins, hobbies or second
jobs associated with chromium exposure
was reported. A more detailed account of
the method for the Bulgarian studies will
be published in the future.
Results
We previously examined DPC in individuals
engaged in mild steel welding, which
results in a much lower level ofchromium-
exposure than stainless-steel welding.
The results of these studies showed a 58%
increase in cross-links in the cases com-
pared with controls, yielding a level ofsig-
nificance ofp= 0.01 (18). We have also
found higher DPC among residents of
Hudson County, New Jersey, who lived
around chromium-containing mine tailings
(19). In this study, control (n=49) levels
ofcross-links were 0.8 ± 0.4, while exposed
subjects had levels of 1.3 ± 0.5 (n= 33)
(p< 0.001) (19). However, chromium
exposure in these studies has not been doc-
umented, and the question of actual
human exposure to chromate remains in
doubt. Similarly, there is uncertainty as to
the cause ofthe elevated DPC.
Recently, we measured airborne, red
and white blood cell, and urinary chro-
mium concentrations to estimate actual
human exposure to chromium. Red blood
cell chromium is currently considered the
best indicator of hexavalent chromium
exposure. Figure 1 shows the excellent cor-
relation between lymphocyte levels ofDPC
and chromium concentrations in red blood
cells among controls in Bulgaria (r=0.62;
p= 0.008). These individuals lived in two
cities, Jambol or Burgas, which experience
strikingly different air pollution. There
was a lack ofcorrelation between urinary
and red blood cell chromium for controls
and chrome platers (data not shown).
Similarly, there was also a lack ofcorrela-
tion between urinary chromium in controls
or chrome platers with lymphocyte DPC
(data not shown). In contrast, there was an
excellent correlation between red blood cell
chromium and DPC among two cities
with different air pollution, as well as
among chrome platers (Figure 2). This
figure illustrates the relationship of red
blood cell chromium and DPC using a
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Figure 1. Correlation of chromium in red blood cells
(RBC) with lymphocyte levels of DNA-protein cross-
links (DPC). Chromium was measured in RBC using
graphite furnace atomic absorption. DPC were mea-
sured in lymphocytes ofthese same individuals. Shown
are controls that lived in Burgas orJambol, Bulgaria.
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Figure 2. Correlation between chromium in red blood
cells and DNA-protein cross-links (DPC). Chromium
was measured in red blood cells of residents of Burgas
(n=6) and Jambol (n= 11) and of chrome platers
(n= 14) using graphite furnace atomic absorption. DPC
were also determined in lymphocytes of these same
individuals. The equation fitting the mode is y= 1.7
(1-el.4(chromium in erythrocytes)) Data in graph are log
transformed. 0, Burgas; A, Jambol; *, chrome
platers.
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nonlinear model. The DPC response
appeared to have obtained its maximum
level at about 7 to 8 ppb chromium levels
in red blood cells (Figure 2), and it did not
increase further when levels ofchromium
were higher in red blood cells, such as in
chrome platers from Bulgaria. The plateau
level as shown by the mathematical model
occurred with a DPC of 1.7%. A more
detailed account of these data will be
published later.
Discussion
It is extremely important to relate the
response ofa biomarker of exposure and
effect to the actual internal dose. In the case
ofchromium, the exposure parameters are
quite complex because this element is both
essential and toxic. The essentiality of the
trivalent form of chromium is not well
understood. It is thought to be involved in
the transport of glucose in cells and the
action ofinsulin on this process. However,
dietary trivalent chromium represents a sub-
stantial contribution to urinary chromium.
This is perhaps why measurement ofurinary
chromium may not be a reliable way to
monitor low-level exposure to hexavalent
chromium. Hexavalent chromium is
actively transported into cells and remains
there for the life ofa cell, whereas trivalent
chromium does not readily enter cells.
Our results clearly show that the red
blood cell levels ofchromium correlate well
with lymphocyte DPC. These two parame-
ters, however, do not correlate with urinary
chromium levels. These findings suggest
that urinary chromium levels may not be a
good way to monitor human exposure to
hexavalent chromium. Measurement ofred
blood cell levels ofchromium is sometimes
problematic due to the interference with a
biological matrix. This problem can be cir-
cumvented by using 02 infusion with
graphite furnace atomic absorption during
the ashing procedure because this will yield
a more complete combustion and eliminate
any possible matrix interference.
An additional important implication of
DPC is that they not only assess exposure
to chromate or other agents inducing such
cross-links, but it measures a biologically
active dose. This goes beyond just measur-
ing the metal level, since the presence of a
metal in a cell does not indicate biological
activity. Metals are stored as inactive com-
plexes in cells, and their presence does not
necessarily constitute a biological effect.
It is difficult to say with certainty whether
the increase in DPC was due to chromium
or some other chemical. Analysis of DPC
showed that they are very reliable biomark-
ers that is not confounded by variables
such as sex, race, weight, or mild smoking
(20). However, issues concerning the per-
sistence of DPC and DNA repair need to
be addressed.
A number of agents produce DPC,
including cis-platinum, formaldehyde, and
UV light. However, UV light and for-
maldehyde are not likely to cause increased
levels of cross-links in peripheral lympho-
cytes. Other unknown environmental
factors may also be involved in elevating
lymphocyte DPC.
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